Literature DB >> 2272770

A phase II trial of echinomycin in metastatic cervix carcinoma.

T Hakes1, M Markman, M Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2272770     DOI： 10.1007/bf00171844

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  3 in total

1.  Cytotoxic activity of echinomycin in a human tumor cloning system.

Authors:  B Lathan; D D Von Hoff
Journal:  Cancer Drug Deliv       Date:  1984

2.  Intermolecular cross-linking of DNA through bifunctional intercalation of an antitumor antibiotic, luzopeptin A (BBM-928A).

Authors:  C H Huang; C K Mirabelli; S Mong; S T Crooke
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

3.  Phase I study of echinomycin administered on an intermittent bolus schedule.

Authors:  J H Harvey; M McFadden; W G Andrews; P J Byrne; J D Ahlgren; P V Woolley
Journal:  Cancer Treat Rep       Date:  1985-12
  3 in total
  2 in total

1.  Characterization of Streptomyces sp. LS462 with high productivity of echinomycin, a potent antituberculosis and synergistic antifungal antibiotic.

Authors:  Caixia Chen; Xiangyin Chen; Biao Ren; Hui Guo; Wael M Abdel-Mageed; Xueting Liu; Fuhang Song; Lixin Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

2.  Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.

Authors:  Sivapriya Ponnurangam; Prasad R Dandawate; Animesh Dhar; Ossama W Tawfik; Rajashri R Parab; Prabhu Dutt Mishra; Prafull Ranadive; Rajiv Sharma; Girish Mahajan; Shahid Umar; Scott J Weir; Aravind Sugumar; Roy A Jensen; Subhash B Padhye; Arun Balakrishnan; Shrikant Anant; Dharmalingam Subramaniam
Journal:  Oncotarget       Date:  2016-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.